“…1B). Since W is conserved within the GBPs of BoNT serotypes A, B, E, F, G and tetanus toxin (17,20,(44)(45)(46)(47), we propose that this mutation can be introduced into each HCR serotype to generate a potentially less reactive but more potent vaccine. In addition, since BoNT/C and BoNT/D possess comparable aromatic residues within another ganglioside binding loop within the HCR (48,49), we propose that the respective W and F may be modified to A to reduce potential reactivity and enhance vaccine potency.…”